Studies have demonstrated that synaptic dysfunctions in AD were the result of oxidative modification of AKT1 by ROS species, and the possible mechanism may be caused by a subsequent reduction in the AKT1 target of mTOR signaling, leading to deficiencies in activity-dependent protein translation [38]. The gene discussed is MTOR; the disease is Alzheimer disease.